N-Zyme Biomedical

Wauwatosa, United States · $4.6M raised

Headquarters
Wauwatosa
Total Funding
$4.6M
Last Round
$4.6M Series AJul 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

N-Zyme Biomedical is a clinical-stage biotechnology company developing first-in-class therapies targeting pepsin, a key driver of tissue damage in reflux disease. The company's lead program is currently being evaluated in Phase 2 clinical trials for laryngopharyngeal reflux (LPR), with additional development planned for patients with proton pump inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD). Through its differentiated mechanism of action, N-Zyme aims to transform the treatment paradigm for reflux disease by addressing one of its underlying causes rather than simply reducing gastric acid. The company is based in Wauwatosa, Wisconsin, with additional operations in Newark, Delaware.

Summary

N-Zyme Biomedical is a Biotech company based in Wauwatosa, United States. It has raised $4.6M in total across 1 round, most recently a $4.6M Series A round in Jul 2026.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJul 2026
$4.6M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

N-Zyme Biomedical on Indexed.vc
<a href="https://indexed.vc/companies/n-zyme-biomedical"><img src="https://indexed.vc/api/badge/company/n-zyme-biomedical" alt="N-Zyme Biomedical on Indexed.vc" width="260" height="76" /></a>